Clincosm LogoSign in Get a demo

Carcinoma, Renal Cell

Showing NaN - NaN of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, MK-4830, Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +5 more
  • New Haven, Connecticut
  • +38 more
Jan 25, 2023

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Favezelimab/Pembrolizumab, Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +5 more
  • New Haven, Connecticut
  • +37 more
Jan 25, 2023

Carcinoma, Renal Cell Trial in Worldwide (Belzutifan, Lenvatinib, Cabozantinib)

Recruiting
  • Carcinoma, Renal Cell
  • Chandler, Arizona
  • +176 more
Jan 19, 2023

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +3 more
  • Birmingham, Alabama
  • +229 more
Aug 11, 2022

Carcinoma, Renal Cell Trial in Dallas (Fitbit Versa)

Terminated
  • Carcinoma, Renal Cell
  • Fitbit Versa
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Feb 21, 2022

Carcinoma, Renal Cell Trial in Worldwide (tivozanib HCl, Sorafenib)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Phoenix, Arizona
  • +190 more
Jan 18, 2022

Carcinoma, Renal Cell Trial in Worldwide (Pazopanib, Sunitinib)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Huntsville, Alabama
  • +226 more
Apr 19, 2021

Data and Safety in Patients Receiving Pazopanib With Advanced or

Completed
  • Carcinoma, Renal Cell
  • Phoenix, Arizona
  • +143 more
Jul 14, 2020

Carcinoma, Renal Cell Trial in Worldwide (axitinib)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Antioch, California
  • +64 more
Apr 18, 2017

Carcinoma, Renal Cell Trial in Worldwide (GW786034, Placebo)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Duarte, California
  • +44 more
Feb 23, 2017

Carcinoma, Renal Cell Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Interferon)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Sacramento, California
  • +41 more
Oct 24, 2014

Carcinoma, Renal Cell Trial in Canada, United States (Sorafenib (Nexavar, BAY43-9006))

Completed
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Bessemer, Alabama
  • +319 more
Aug 5, 2014

Carcinoma, Renal Cell Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • Tucson, Arizona
  • +120 more
Jan 8, 2014

Carcinoma, Renal Cell Trial in Worldwide (Sutent)

Approved for marketing
  • Carcinoma, Renal Cell
  • Scottsdale, Arizona
  • +273 more
Mar 8, 2012

Carcinoma, Renal Cell Trial in United States (Sunitinib Malate Continuous Daily Dosing, Sunitinib Malate Schedule 4/2)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Sunitinib Malate Continuous Daily Dosing
  • Sunitinib Malate Schedule 4/2
  • Hot Springs, Arkansas
  • +158 more
Aug 3, 2011

Carcinoma, Renal Cell Trial in Worldwide (Interferon-alfa, SU011248)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Jonesboro, Arkansas
  • +123 more
Jan 19, 2010

Carcinoma, Renal Cell Trial in United States (Sunitinib)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Duarte, California
  • +10 more
Jan 6, 2010

Carcinoma, Renal Cell Trial in Netherlands, United States (ABT-510/Thrombospondin-1 mimetic)

Completed
  • Carcinoma, Renal Cell
  • ABT-510/Thrombospondin-1 mimetic
  • Scottsdale, Arizona
  • +17 more
Aug 13, 2007